In this study, we analyzed lymphocyte subpopulations—CD4+, CD8+, CD19+—and surface antigen CTLA-4 in patients with different types of PAH: CHD-PAH, CTD-PAH, CTEPH and iPAH. This evidence concerns the gene CD4 and chronic thromboembolic pulmonary hypertension.